Cigarette smoke is the major cause of chronic obstructive pulmonary disease (COPD), a chronic inflammatory disease of the airway. The increased expression of inflammatory proteins results from enhanced gene transcription, as these mediators are induced in a cell-specific manner. Changes in transcription depend on chromatin remodeling and the relative activities of histone acetyl-transferases (HATs) and histone deacetylases (HDACs). We have shown that cigarette smoke reduces the expression of HDAC2 expression and HDAC activity in biopsies and alveolar macrophages. Cigarette smoke also enhanced IL-1β-induced expression of tumor necrosis factor . 71)-α) by alveolar macrophages. TNF-α release was enhanced by the HDAC inhibitor Trichostatin A and correlated significantly with HDAC activity. In addition, we show that glucocorticoid-responsiveness is reduced in these cells and correlates with HDAC activity. Using a macrophage cell line, we show that hydrogen peroxide mimics cigarette smoke effects on HDAC activity and markedly attenuates dexamethasone inhibition of cytokine release. These results offer the first evidence for a suppressive effect of cigarette smoke on histone acetylation status. Reduced HDAC expression may account for the enhanced expression of inflammatory mediators such as GM-CSF, IL-8 and TNF-α by cigarette smoke seen in lavage samples of smokers and patients with COPD. In addition, this mechanism may account for the reduced effectiveness of glucocorticoids in COPD.
nflammation is a central feature of many lung diseases, including asthma and chronic obstructive pulmonary disease (COPD) (1) . Cigarette smoking is the main cause of COPD, but we do not yet know the mechanisms by which this process leads to inflammation. The inflammatory response involves the recruitment and activation of inflammatory cells and changes in the structural cells of the lung. This action is reflected in increased expression of multiple proteins involved in a complex inflammatory cascade (2) . The increased expression of most of these proteins is the result of enhanced gene transcription because many of the genes are not expressed in normal cells under resting conditions but are induced in inflammatory diseases I in a cell-specific manner (2) . In contrast to asthma, the inflammation seen in COPD does not respond to corticosteroids (1) .
DNA is wound around histone proteins to form nucleosomes and the chromatin fiber in chromosomes (3) . It has long been recognized that chromatin, at a microscopic level, may become dense or translucent, which is caused by the winding or unwinding of DNA around core histones (4) . Acetylation of histone residues results in the unwinding of DNA coiled around the histone core, thus opening up the chromatin structure, which allows transcription factors and RNA polymerase II to bind more readily, thereby increasing gene transcription (3, 5) .
The transcriptional co-activators CBP and PCAF have intrinsic histone acetylation activity, which is activated by the binding of transcription factors such as AP-1 and NF-κB (6) . Repression of genes is associated with reversal of this process by histone deacetylation (6) . Deacetylation of histones increases the winding of DNA around histone residues and results in a dense chromatin structure and reduced access of transcription factors to their binding sites, thereby leading to repressed transcription of inflammatory genes (7) . Thus, increased gene transcription is associated with an increase in histone acetylation, whereas hypo-acetylation is correlated with reduced transcription or gene silencing (6) .
Histone acetylation is an active process whereby small changes in acetylases or deacetylases can markedly affect the overall histone acetylase activity associated with inflammatory genes (8) . Thus, hyperacetylation and increased gene expression may result from increased histone acetyltransferases (HAT) activation or a reduction in histone deacetylase (HDAC) activity or expression. In addition, we have recently described a requirement for HDAC recruitment to activated transcriptional complexes for full glucocorticoid actions to occur (9) .
The objective of this study was to investigate whether cigarette smoking affected histone acetylation and/or deacetylation, and subsequently inflammatory gene expression in relevant cells within the lung. We measured HDAC activity and the localization and expression of histone acetylases and deacetylases in biopsies and bronchoalveolar lavage (BAL) macrophages from normal nonsmoking subjects and 13 age-matched healthy cigarette smokers. These results were correlated with induction of inflammatory genes in BAL macrophages and their ability to respond to glucocorticoids. Finally, we examined whether changes in HDAC activity by oxidant stress results in increased inflammatory gene expression and changes in glucocorticoid responsiveness in the human monocyte/macrophage cell line U937 and the human pulmonary epithelial cells line A549.
MATERIALS AND METHODS

Subjects
We used biopsy samples and BAL macrophages from 16 nonsmoking normal subjects (mean age 26.9 ± 1.2 y, 11 male) and 13 age-matched healthy cigarette smokers (mean age 29.0 ± 1.8 y, 6 male, >20 pack years). Bronchial biopsies and lavage were performed according to the local Ethics Committee Guidelines (Royal Brompton Hospital).
Fiberoptic bronchoscopy
Subjects attended the bronchoscopy suite at 8.30 a.m. after having fasted from midnight and were pretreated with atropine (0.6 mg, i.v.) and midazolam (5-10 mg, i.v.). Oxygen (3 l/min) was administered via nasal prongs throughout the procedure, and oxygen saturation was monitored with a digital oximeter. We used local anesthesia with lidocaine (4%) on the upper airways and larynx, and passed a fiberoptic bronchoscope (Olympus BF10 Key-Med, Southall, U.K.) through the nasal passages into the trachea. Multiple mucosal biopsies were taken from segmental and subsegmental bronchi. Warmed saline (4 × 60 ml) was instilled into the airways to enable recovery of BAL cells. BAL cells were spun (500 x g for 10 min) and washed twice with Hanks buffered salt solution (HBSS). Cytospins were prepared and stained with May-Grunwald stain for differential cell counts. Cell viability was assessed by using the trypan blue exclusion method. Cells (1 × 10 6 ) were incubated in 24-well plates in RPMI without phenol red and 10% fetal calf serum (FCS, Sigma, Poole, U.K.) for 4 h before attached cells were discarded and remaining cells were kept in RPMI containing 0.25% FCS for at least 6 h before stimulation. Cells were stimulated with IL-1β (1 ng/ml) or IL-1β + trichostatin A (TSA, 100 ng/ml).
Bronchial mucosal biopsies were washed in HBSS before immediately being placed in optimal cutting temperature (OCT) embedding media, then snap-frozen in isopentane precooled with liquid nitrogen and stored at -70°C. Six-micron sections were cut on a cryostat and placed on poly-L-lysine-coated microscope slides (Sigma). The slides were air-dried for 30 min, then wrapped in aluminum foil and stored at -70°C prior to immunostaining. Other biopsies were stored in lysis buffer (10 mM Tris-HCl, pH 6.5, 50 mM sodium bisulphite, 10 mM MgCl 2 , 8.6% sucrose, 2% Triton X-100, protease cocktail) at -70°C to be used for HDAC assays. After thawing tissue samples were homogenized with an A-type Dounce homogenizer and the nuclei collected by microcentrifugation, nuclei were incubated on ice for 30 min in HDAC buffer A (15 mM Tris-HCl, pH 7.9, 450 mM NaCl, 0.25 mM EDTA, 10 mM 2-mercaptoethanol, 10% glycerol) before centrifugation and the NaCl concentration was restored to 150 mM by using HDAC buffer B (15 mM Tris-HCl, pH 7.9, 0.25 mM EDTA, 10 mM 2-mercaptoethanol, 10% glycerol). The soluble proteins represent the crude HDAC preparations.
Immunostaining of HDACs (HDAC1 and HDAC2)
Frozen sections and BAL macrophage cytospins were allowed to warm to room temperature, were fixed in cold acetone at -20°C for 5 min, and air-dried for 10 min. Endogenous peroxidase activity was blocked by incubating sections with methanol containing 3% hydrogen peroxide with 0.02% sodium peroxide for 1 h. Immunostaining procedures were performed by using the Vectra Stain kit (Vectra Laboratories, Peterborough, U.K.). Nonspecific labeling was blocked by coating with 20% normal goat serum for 20 min at room temperature. After being washed in PBS, the tissues were incubated with a goat polyclonal anti-human HDAC1 or HDAC2 antibodies (Santa Cruz, Santa Cruz, Calif.; diluted 1:25 in 0.5% Triton X-100/PBS) at room temperature for 2 h. After incubation and repeated washing steps with PBS, the sections were subsequently incubated with biotinylated rabbit anti-goat IgG (1:200) for 1 h at room temperature. We washed the slides and then applied avidin-biotin complex for 45 min. Secondary antiserum was detected with a 3, 3' diaminobenzidine (Sigma). Sections were counter-stained with haematoxylin and mounted with mounting medium (DPX).
Western blotting
Total cellular proteins were extracted from biopsy samples and alveolar macrophages by freezethawing samples in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, protease inhibitor cocktail (Boehringer Mannheim, Lewes, U.K.)) (10) . W resuspended 30-50 µg of soluble proteins from the cell lysate in 4× Laemmli sample buffer. Pellets were size-fractionated on 10% PAGE gels and transblotted onto Nitrocellulose-ECL membranes (Amersham-Pharmacia, Amersham, U.K.). Membranes were blocked 45 min with 5% skimmed milk at 18°C before incubation with 1:800 rabbit anti-human CBP, or 1:800 goat anti-human PCAF, HDAC1 or HDAC2 antibodies (Santa Cruz) at 18°C for 2 h. The level of loading was controlled by determining β-actin expression (1:1000, Santa Cruz). After washing (3×, 10 min in PBS-Tween), bound antibody was detected by using 1:4000 rabbit anti-goat or goat anti-rabbit antibody (Dako) linked to horseradish peroxidase, and bound complexes detected using ECL (Amersham-Pharmacia).
HDAC activity
Radiolabeled histones were prepared from A549 cells after incubation with TSA (100 ng/ml, 6 h) in the presence of 0.1 mCi/ml [ 3 H]acetate. Histones extracted by acid and precipitated with cold acetone were dried and resuspended in distilled water. Crude HDAC preparations were extracted from total cellular homogenates with Tris-based buffer (10 mM Tris-HCl, pH 8.0, 500 mM NaCl, 0.25 mM EDTA, 10 mM 2-mercaptoethanol) as previously reported (11) . The crude HDAC preparation were incubated with [
3 H]-labeled histone for 1 h at 30°C before the reaction was stopped by the addition of 1N HCl/0.4N acetic acid. Released [ 3 H]-labeled acetic acid was extracted by ethylacetate, and the radioactivity of the supernatant was determined by liquid scintillation counting (11) .
TNF-α and IL-8 ELISAs
Determination of TNF-α and IL-8 expression was measured by sandwich ELISA (Duoset, R&D, Abingdon, U.K.), according to the manufacturer's instructions. Recombinant human IL-8 and TNF-α (R&D Systems; Abingdon, U.K.) were used as standards. Alveolar macrophages (1 × 10 6 ) were stimulated with IL-1β (1 ng/ml) or TSA (100 ng/ml) individually or in combination for 24 h before supernatants were measured.
RNA isolation and RT-PCR
PCR primers were as follows (annealing temperature and product size appear in parentheses): HDAC1 sense 5'-CCC AAT gAA gCC TCA CCg AAT-3' and antisense 5'-TCg gAg Cgg gTA gTT AAC AgC-3' (67°C, 604 bp); HDAC2 sense 5'-CCC TgA ATT TgA Cag TCT CACC-3' and antisense 5'-CAC AAT AAA ACT TgC CCA gAA AAA-3' (62°C, 175 bp). GM-CSF, GAPDH and β-actin primers were purchased from R&D Systems and used according to the manufacturer's instructions. Extraction of RNA from BAL macrophages and A549 cells was performed by using RNeasy Mini Kit according to the manufacturer's instructions (Qiagen, Crawley, U.K.). Sample RNA was quantified by spectrophotometry, and 1 µg was reversetranscribed to cDNA as previously described (12) . PCR reactions were performed on 5 µl of the cDNA with a Hybaid Omnigene thermal cycler (Hybaid, Ashford, Middlesex, U.K.) in a final reaction volume of 25 µl in the presence of 0.4 U of Taq DNA polymerase. Thirty-five cycles were used, with a denaturing step at 94°C for 45 s, followed by the specific primer annealing temperature for 45 s and an extension step at 72°C for 45 s.
Chromatin Immunoprecipitation (ChIP) assay
A-549 cells were treated with IL-1β (1 ng/ml) in the presence of dexamethasone (10 -6 M) or TSA (100 ng/ml). ChIP assays were performed exactly as described previously except that a pan acetylated histone H4 antibody was used for immunoprecipitations (9) . Protein-DNA complexes were fixed by formaldehyde (1% final concentration) and cells sonicated (3 × 10 s pulses) on ice. Sonicated samples were immunoprecipitated, and protein-bound immunoprecipitated DNA was treated successively for 4 h at 65°C in 200 mM NaCl/1% SDS to reverse crosslinks and incubated for 1 h at 45°C with 70 µg/ml Proteinase K (Sigma). DNA was extracted with phenol/chloroform, ethanol precipitated and GM-CSF promoter associated DNA amplified by PCR. Primer pairs for GM-CSF were GM-CSF forward 5'-CTg ACC ACC TAg ggA AAA ggC, GM-CSF reverse 5'-CAg CCA CAT CCT CCT CCA gAg AAC. PCR products were resolved by 3% agarose-gel and visualized with ethidium bromide.
Cell culture
U937 cells (ECACC code 85011440) were cultured at 37°C in a humidified atmosphere with 5% CO 2 in RPMI 1640 medium (Sigma) supplemented with 10% FCS and 2 mM L-glutamine and were maintained between 5-15 × 10 5 cells/ml. Cells were stimulated with LPS (500 ng/ml, Salmonella enteridides, Sigma) or LPS and 100 µM H 2 O 2 (Sigma) in RPMI medium as above in 0.25% FCS at 5 × 10 5 cells/ml. Dexamethasone was added 30 min before stimulation and IL-8 and TNF-α release measured by ELISA after 24 h. A549 cells were cultured as described previously (9) .
Statistics
Results are expressed as mean ± standard error of the mean (SE). A multiple comparison was made between the mean of the control and the means from each individual treatment group by Dunnett's test by using SAS/STAT software (SAS Institute Inc., Cary, N.C.). We performed all statistical testing by using a two-sided 5% level of significance.
RESULTS
Localization of HATs and HDACs in bronchial biopsies
Immunohistochemical analysis of HAT and HDAC expression in biopsy samples from normal and smoking subjects indicated that CBP, PCAF, HDAC1, and HDAC2 are localized within the airway to all cells. The most intense staining is seen within the epithelium and inflammatory cells. Smoking did not affect the site of the expression of any of these proteins (Fig. 1) .
Expression of HATs and HDACs in bronchial biopsies
Using Western blot analysis, we were unable to detect any difference in the level of CBP or PCAF expression in biopsies between the two groups (Fig. 2a) . In contrast, there was a decrease in HDAC2 expression (0.63 ± 0.02 versus 0.37 ± 0.06 OD units, p<0.01), but not HDAC1 (0.55 ± 0.07 versus 0.55 ± 0.10 OD units) protein in samples extracted from cigarette smokers (Figs.  2b, c) .
HDAC activity in bronchial biopsies
HDAC activity, as measured by release of 3 H-acetic acid from labeled histones, was reduced in biopsy samples from smokers (111 ± 11 dpm/µg protein, n=13) as compared with nonsmoking controls (146 ± 14 dpm/µg protein, n=14, p<0.01) (Fig. 2d ). This correlated with the reduction in HDAC2 protein expression.
HDAC expression and activity in BAL macrophages
There was a significant reduction in HDAC2-but not HDAC1-expression in BAL macrophages isolated from smokers as determined by immunocytochemistry (Fig. 3a) . This reduction was confirmed by the detection of a significant reduction in HDAC2 expression in these cells when analyzed by Western blotting (Fig. 3b) . HDAC1 expression was not altered. These changes in protein expression were due to changes in the expression of mRNA for HDAC2 because BAL macrophages had reduced expression of HDAC2, but not HDAC1, mRNA as determined by RT-PCR. We also detected decreased HDAC activity in BAL macrophages isolated from smokers (59.1 ± 8.4 dpm/µg protein, n=6) compared with nonsmoking controls (120 ± 11 dpm/µg protein, n=6, p=0.0012) (Fig. 3d ). This correlated with the reduction in HDAC2 expression.
Cytokine production in BAL macrophages
Reduced HDAC activity should lead to increased inflammatory gene expression following cell stimulation. Therefore, we have measured IL-1β-stimulated TNF-α and IL-8 release. Although basal release of TNF-α was unaltered between groups (0.51 ± 0.09 versus 0.58 ± 0.12 ng/ml), IL-1β-stimulated TNF-α release was significantly increased in both groups but with a greater increase in smokers (n=6) than in nonsmokers (2.06 ± 0.28 versus 0.83 ± 0.1 ng/ml, n=6, p<0.05) (Fig. 4a) . In addition, there was a significant correlation between IL-1β-stimulated TNF-α release and HDAC activity (r=-0.79, p=0.0021). Stimulation of cells with TSA, an inhibitor of HDAC activity (Fig. 4b) , significantly enhanced IL-1β-stimulated TNF-α release in both groups. This reached the level seen in IL-1β-stimulated cells in smokers. TSA and IL-1β together enhanced TNF-α release in nonsmokers to levels seen in smokers, whereas TSA failed to further enhance IL-1β-stimulated TNF-α production in smokers. There was a significant correlation between HDAC activity and the ratio between IL-1β-stimulated and maximal TNF-α release (IL-1β + TSA, r = -0.94, p<0.0001). IL-1β-stimulated IL-8 release was greater in smokers (n=6) than in nonsmokers (1.54 ± 0.2 vs. 1.24 ± 0.14 ng/ml, n=6), although this finding failed to reach significance (p=0.073) (Fig. 4c) . There was a significant correlation between the ratio between IL-1β-stimulated and maximally stimulated IL-8 expression and HDAC activity (r = -0.92, p<0.0001). IL-1β-stimulated GM-CSF release was greater in smokers (n=6) than in nonsmokers (1.02 ± 0.16 vs. 0.48 ± 0.06 ng/ml, p<0.05, n=6) (Fig. 4d) . There was a significant correlation between the ratio between IL-1β-stimulated (r = -0.66, p<0.01) and maximally stimulated GM-CSF expression and HDAC activity (r = -0.90, p<0.0001).
Effect of smoking on dexamethasone repression of cytokine release in BAL macrophages
Reduced HDAC activity should also limit glucocorticoid actions in these cells. We therefore examined the effect of dexamethasone on IL-1β-stimulated TNF-α release in BAL macrophages from smokers and nonsmokers. In nonsmokers, dexamethasone (10 -6 M) suppressed TNF-α release by 77%. In contrast, macrophages from smokers had a reduced dexamethasone responsiveness with only 34% fall in TNF-α release (Fig. 5a) . Similar results were seen for IL-8 release. In nonsmokers dexamethasone suppressed IL-8 release by 64% and by 29% in smokers (Fig. 5b) . There was a significant correlation between HDAC activity and the inhibitory effect of dexamethasone on both TNF-α release (r = 0.88, p<0.0001), IL-8 release (r = 0.65, p=0.029), and GM-CSF release (r=0.xx, p<0.0001). Using Western blot analysis, we confirmed that the reduced effect of dexamethasone was not due to a reduction in glucocorticoid receptor (GR) expression in these cells (Fig. 5c ).
To confirm that this effect occurred at the transcriptional level, we examined GM-CSF mRNA following IL-1β and TSA treatment in BAL macrophages from smokers and nonsmokers (Fig.  5d) . IL-1β-stimulated GM-CSF mRNA was expressed at higher levels in smokers than in nonsmokers and was enhanced following combined IL-1β/TSA treatment in the nonsmokers but not smokers. TSA alone had no effect on GM-CSF mRNA expression (upper left panel). Using a ChIP assay examining the GM-CSF promoter associated with pan acetylated histone H4, we found that smokers had more GM-CSF associated with acetylated histones than nonsmokers and that this was increased to a greater extent in nonsmokers than smokers following TSA treatment (lower left panel). Dexamethasone produced a decrease in GM-CSF mRNA expression in BAL macrophages, whereas no change was seen in macrophages from smokers (upper right panel). These data were confirmed by using ChIP assays with a pan acetylated histone H4 antibody showing that GM-CSF promoter associated acetylated histones were reduced by dexamethasone to a greater extent in smokers than in nonsmokers (Fig. 5d) .
Effect of oxidative stress on dexamethasone repression of cytokine release in cultured cells
To model whether cigarette smoking-induced reduction in HDAC activity could increase inflammatory gene expression, we examined the effect of oxidant stress (100 µM H 2 O 2 ) on GM-CSF release and inhibition by dexamethasone in A549 cells (Fig. 6a) . IL-1β caused a significant increase in GM-CSF (23.0 ± 4.4 versus 714 ± 93.6 pg/ml) that was inhibited 96% by dexamethasone (1 µM) (Fig. 6a) . Trichostatin A (TSA, 10 ng/ml) reduced HDAC activity (165 ± 16 versus 10.4 ± 5.4 dpm/10 µg protein) and inhibited the ability of dexamethasone (1 µM) to reduce GM-CSF release (96% inhibition vs. 49% inhibition). Hydrogen peroxide (100 µM) enhanced IL-1β-stimulated GM-CSF release (1280.5 ± 103 versus 714.3 ± 93.6 pg/ml) and reduced dexamethasone inhibition to equivalent levels seen in the presence of TSA (52% inhibition). The potency of dexamethasone was also altered, which reflected a reduced sensitivity (IC 50 = 2.0 × 10 -9 M versus 1.1 × 10 -7 M, p<0.05). H 2 O 2 alone had no effect on GM-CSF production. Similar results were seen with LPS-induced IL-8 production in U937 cells (Fig. 6b) . In these cells dexamethasone (10 -8 M) had a reduced ability to suppress LPS-stimulated IL-8 production in the presence of TSA and H 2 O 2 than that seen in A549 cells. TSA (100 ng/ml) caused a marked suppression of HDAC activity (120 ± 11 vs. 12 ± 5.4 dpm/10 µg protein). H 2 O 2 gave a concentration-dependent inhibition of HDAC activity, which reached a level of 63% of control at 100 µM H 2 O 2 (Fig. 6c) . There was no effect of H 2 O 2 on HDAC expression as measured by Western blotting at time points up to 24 h (data not shown). In the absence of H 2 O 2 , there was a concentration-dependent inhibition of LPS-induced IL-8 production by dexamethasone (IC 50 of 1.0 × 10 -9 M) (Fig. 6d) . Following H 2 O 2 (100 µM) costimulation for 4 h, we found a significant increase in LPS-induced IL-8 production and a reduced effectiveness of dexamethasone to suppress IL-8 release. The maximal suppression reached was 25% of the maximal stimulus. H 2 O 2 alone had no effect on IL-8 production (Fig. 6d) .
DISCUSSION
We have shown that cigarette smoking is associated with a reduction in HDAC2 expression and activity in bronchial biopsies and alveolar macrophages. This finding is correlated with an increase in basal and IL-1β-stimulated TNF-α expression in alveolar macrophages. The level of HDAC activity is inversely correlated with maximal TNF-α and IL-8 production in these cells. Previous data have suggested that increased histone acetylation is associated with gene induction (6), and we confirm this for GM-CSF mRNA in BAL macrophages from both smokers and nonsmokers. The overall acetylation status of histones depends on the dynamic equilibrium between HAT and HDAC activities. Repression of HDAC activity can lead to enhanced histone acetylation and increased gene expression. This finding appears most noticeably with the HDAC inhibitor trichostatin A (TSA), which induces increased expression of inflammatory genes following an inflammatory stimulus (13) . Indeed, we show that TSA causes the expected enhanced release of the cytokines GM-CSF, TNF-α and IL-8 in this study and acts at the transcriptional level, at least for GM-CSF. These results provide the first evidence for a suppressive effect of cigarette smoking on histone acetylation status. This effect results in increased acetylation, causes local unwinding of DNA, and allows increased inflammatory gene expression to occur (14) .
We have previously shown that glucocorticoid suppression of inflammatory genes requires recruitment of HDACs to the activation complex by the GR (9). This implies that reduced HDAC activity will not only increase inflammatory gene expression but will also cause a reduction in glucocorticoid function. Indeed, we show that this is the case in BAL macrophages from smokers and in A549 and U937 cells following oxidative stress (hydrogen peroxide). These data suggest that one potential reason for the failure of glucocorticoids to function effectively in reducing inflammation in COPD is that oxidative stress may reduce HDAC activity and expression. Alternatively, the reduced HDAC activity could also be explained by decreased expression or activity of other HDACs (3-8), which we did not examine here.
H 2 O 2 produced a decrease in HDAC activity and a subsequent enhancement of IL-1β-stimulated cytokine production. The mechanism of this effect is at present unclear, although previous studies have suggested a role for MAPK activation and stimulation of the transcription factors AP-1 and NF-κB (15) . In our system the exact mechanism by which oxidative stress modulates HDAC activity is unclear, although it is thought to involve modulation of HDAC phosphorylation and nitrosylation on distinct tyrosine residues (Ito and Adcock, unpublished results).
Cigarette smoke causes an inflammatory cascade, which results in the production of many inflammatory mediators in important regulatory cells within the airway, including epithelial cells, neutrophils, and alveolar macrophages (16, 17) . Cigarette smoke contains high concentrations of reactive oxygen species (ROS), such as superoxide and other free radicals (18) . Exposure of lungs to these ROS leads to an accumulation of neutrophils in alveolar walls (19) and BAL fluid (20) . This accumulation is caused by the induction of chemotactic factors such as IL-8 in the lung and particularly within alveolar macrophages (21) . Others reports have suggested that IL-8 may be released from the airway epithelium following induction of the complement C5a receptor leading to enhanced C5a-mediated IL-8 release (22) . In addition to neutrophils, IL-8 is also chemotactic to eosinophils, and cigarette smoke has been shown to increase airway eosinophilia in biopsies and BAL (23) . Further analysis revealed that these infiltrating cells are activated with enhanced levels of MPO and ECP present in both biopsy specimens and BAL fluid (23) . Ex vivo studies have also shown that cigarette smoke can enhance TNF-α production from human monocytes (24) .
Earlier studies have also reported increased IL-8 expression and neutrophilia associated with cigarette smoking but in addition found elevated numbers of macrophages and increased expression of the inflammatory mediators IL-1β, IL-6 and MCP-1 (25) . Macrophages play an important role in tissue repair and remodeling after inflammatory insults to the airway (26) . Cigarette smoke has been reported to increase basal metabolism of macrophages and enhance LPS-responsiveness but that it suppresses that to IFN-γ in vitro (27) . This excessive activation of macrophages may result in release of proteinases and parenchymal destruction that occurs in emphysema (1).
In contrast to results reported here, previous studies have reported that cigarette smoking causes a decrease in LPS-induced cytokine release from BAL macrophages (28) (29) (30) (31) or have reported no change (32) . We have examined IL-1β-stimulated cells and observed an increase in cytokine release. A simplistic explanation for these effects may be that smoking reduces the expression of CD14/Toll or other aspects of its signaling pathway (33) . This condition may account for the observation that other aspects of macrophage activation are increased in cells isolated from smokers (34) (35) (36) .
COPD poorly to corticosteroid therapy. High doses of oral and inhaled corticosteroids have no inhibitory effect on the inflammatory cells or cytokines in induced sputum of patients with COPD, in contrast to a potent effect on patients with asthma (37, 38) . The reasons for this lack of response are nor known, but our study suggests that cigarette smoking reduces the response to cortocosteroids by decreasing HDAC activity in key inflammatory cells such as alveolar macrophages. In asthmatic subjects who smoke, there appears to be a marked reduction in response to inhaled corticosteroids (39) .
In summary, we show that reduced HDAC expression may account for the enhanced expression of inflammatory mediators such as GM-CSF, IL-8, and TNF-α by cigarette smoke seen in biopsy and lavage samples of smokers (23) . We have previously shown that glucocorticoids, through the GR, act, at least in part, by recruitment of HDAC to the activating transcription factor complex in a manner similar to that for Rb repression of transcription (40) . Therefore, we postulate that reduced expression of HDAC proteins and reduced HDAC activity may also reduce GR recruitment of HDAC activity to a repressor complex, which thus limits glucocorticoid effectiveness in suppressing inflammation, as evidenced in these studies and clinically in patients with COPD (37) .
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